US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

909.36

+16.281.82%

Number of Gainers:68

Number of Losers:97

Number of Flat:11

PE:- -

High:929.43

Open:895.79

Low:895.77

Close:893.08

Volume:279.67M

Turnover:13.02B

Market Cap:675.96B

Float Cap:485.43B

Loading ...

Nuvalent Chief Development Officer Darlene Noci Reports Sale of Common Shares

Small U.S. Stocks Finish Mixed As Falcon's Beyond Global Leads, Janux Therapeutics Lags

Biomea Fusion Inc. CEO and Director Rainer M. Erdtmann Reports Acquisition of Common Shares

Zenvia Inc. Shareholders to Vote on Approval of 2024 Financial Statements at Upcoming AGM

Unicycive Therapeutics unveils new kidney disease treatment pipeline in latest corporate presentation

Top Midday Decliners

MT Newswires Live

A Look at Robinhood (HOOD) Valuation Following Recent Volatility and Surging Returns

Simply Wall St.

Ryan Specialty Rebrands NAPL Team as Ryan Financial Lines in Global Expansion

RxSight Is Maintained at Equal-Weight by Morgan Stanley

Robinhood CEO Says Gen Z Is Obsessed With 'Grandparent' Products Like Cassette Tapes And Walkmans—And Now They're Opening Retirement Accounts At 19

Benzinga_recent_news

Coinbase Global: Aware That Some Users May Be Experiencing Delayed Sends and Receives on Osmosis Network

THOMSON REUTERS

Coinbase Global Inc: Buys, Sells, and Fiat Withdrawals/Deposits Remain Unaffected on Osmosis Network

THOMSON REUTERS

Gold Down Over 1%; Signet Shares Fall After Q3 Results

What's Going On With Cancer Firm Kazia Therapeutics

Oklo Volatility Play: Traders Get A New 2X Inverse Weapon With Defiance's OKLS

Benzinga_recent_news

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

How to build the perfect investor: 50% Generation X and 50% Gen Z

SentinelOne Unveils New Innovations and Integrations With AWS to Accelerate Customers’ AI Initiatives at AWS Re:Invent 2025

THOMSON REUTERS

BRIEF-Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology For Oligomer-Selective Antibodies

Press Release: Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4539/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":909.36115,"timestamp":1764709199999,"preClose":893.0781,"halted":0,"volume":279671509,"delay":0,"changeRate":0.018232,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":16.28302,"latestTime":"12-02 16:00:00 EST","open":895.7881,"high":929.42596,"low":895.77374,"amount":13017366032.411278,"amplitude":0.037681,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.332433,"peRate":161.231531,"turnoverRate":0.020395,"increases":69,"decrements":96,"flats":7,"marketCap":675955485414.75,"floatMarketCap":485431095434.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":929.42596,"amplitude":0.037681,"preClose":893.0781,"low":895.77374,"pbRate":"7.332433","latestPrice":909.36115,"volume":279671509,"delay":0,"open":895.7881,"prevYearClose":648.26935,"prevWeekClose":898.8388,"prevMonthClose":898.8388,"prevQuarterClose":1016.6711,"fiveDayClose":843.0314,"twentyDayClose":978.983,"sixtyDayClose":882.0353,"secType":"PLATE","market":"US","turnoverRate":0.020395,"peRate":161.231531,"marketCap":675955485414.75,"floatMarketCap":485431095434.25,"timestamp":1764709199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":68,"down":97,"flat":11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588069519","title":"Nuvalent Chief Development Officer Darlene Noci Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588069519","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588069519?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:31","pubTimestamp":1764711091,"startTime":"0","endTime":"0","summary":"Darlene Noci, Chief Development Officer of Nuvalent Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvalent Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLgLJJm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvalent Chief Development Officer Darlene Noci Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2588015066","title":"Small U.S. Stocks Finish Mixed As Falcon's Beyond Global Leads, Janux Therapeutics Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2588015066","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588015066?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:21","pubTimestamp":1764710460,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Tuesday, as the Russell 2000 Index fell 0.2%, while the S&P Small Cap 600 Index was up 0.1%.Among companies with a market value of $1 billion to $6.7 billion, Janux Therapeutics Inc. was the biggest laggard during the session, dropping 53%, followed by shares of American Bitcoin Corp., which dropped 39%. Shares of Coincheck Group N.V. dropped 19%, UroGen Pharma Ltd. shares tumbled 14%, and Hotel101 Global Holdings Corp. tumbled 14%.Falcon's Beyond Global Inc. was the best performer, surging 20%, followed by TMC the metals company Inc., which surged 18%. WeShop Holdings Ltd. shares surged 17%, Vera Therapeutics Inc. surged 13%, and shares of Eve Holding Inc. jumped 12%.Major stock indexes in the U.S. climbed Tuesday with the Nasdaq Composite Index increasing 0.6%. Meanwhile, the S&P 500 Index added 0.2%, and the Dow Jones Industrial Average added 0.4%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JANX"],"gpt_icon":0},{"id":"2588306620","title":"Biomea Fusion Inc. CEO and Director Rainer M. Erdtmann Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588306620","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588306620?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:15","pubTimestamp":1764710136,"startTime":"0","endTime":"0","summary":"Rainer M. Erdtmann, Director and Officer at Biomea Fusion Inc., reported an acquisition of common shares of Biomea Fusion Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomea Fusion Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL3q1qbG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Biomea Fusion Inc. CEO and Director Rainer M. Erdtmann Reports Acquisition of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4539","BMEA","BK4139"],"gpt_icon":0},{"id":"2588066446","title":"Zenvia Inc. Shareholders to Vote on Approval of 2024 Financial Statements at Upcoming AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066446","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066446?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:13","pubTimestamp":1764709997,"startTime":"0","endTime":"0","summary":"Zenvia Inc. has announced that shareholders will vote on the approval and ratification of the company's financial statements and auditor's report for the fiscal year ended December 31, 2024, at the upcoming Annual General Meeting scheduled for December 19, 2025. The Board of Directors recommends voting in favor of the proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenvia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL6HJzyD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","ZENV"],"gpt_icon":0},{"id":"2588065920","title":"Unicycive Therapeutics unveils new kidney disease treatment pipeline in latest corporate presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2588065920","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588065920?lang=en_us&edition=fundamental","pubTime":"2025-12-03 04:22","pubTimestamp":1764706977,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics Inc. has released a corporate presentation detailing its current pipeline and development strategy in the field of kidney disease. The company's lead asset, oxylanthanum carbonate , is being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Unicycive plans to resubmit the New Drug Application  for OLC by the end of the year, following discussions with the FDA regarding the resolution of a previously identified manufacturing vendor compliance issue. If approved, OLC is expected to offer a lower pill burden compared to existing therapies, addressing a significant unmet need according to surveyed nephrologists. The company is also advancing UN-494, which is in development for the treatment of acute kidney injury and chronic kidney disease. Unicycive reports a cash runway extending into 2027 to support its ongoing clinical and commercial activities. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL3m38WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"gpt_icon":0},{"id":"2588063112","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2588063112","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588063112?lang=en_us&edition=fundamental","pubTime":"2025-12-03 03:25","pubTimestamp":1764703548,"startTime":"0","endTime":"0","summary":"Sonnet BioTherapeutics  reported Tuesday that its stockholders have approved, among other things, the proposed business combination with Hyperliquid Strategies Inc and Rorschach I LLC.Shares of the company slumped 55% following an increase in intraday trading volume to over 7 million from a daily average of roughly 958,000.Janux Therapeutics  shares plunged 51% after the company reported late Monday interim data from its phase 1 trial of the JANX007 drug candidate to treat metastatic castration-resistant prostate cancer.More than 11.5 million shares of the company traded intraday compared with a daily average of about 1 million.Health In Tech  said Tuesday its executive management team, vice presidents, and the board have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional six months beyond the original 12-month lock-up in connection with its initial public offering last year.Shares of the company dropped 21% as intraday trading volume rose t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4173","JANX","HIT.AU","BK7057","BK4139","SONN","HIT","BK4539"],"gpt_icon":0},{"id":"2588065899","title":"A Look at Robinhood (HOOD) Valuation Following Recent Volatility and Surging Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2588065899","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588065899?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:34","pubTimestamp":1764700482,"startTime":"0","endTime":"0","summary":"Robinhood Markets (HOOD) has seen its stock performance shift over the past few months, catching the attention of investors curious about what is next for the popular trading platform.\nSee our latest analysis for Robinhood Markets.\nRobinhood’s share price has been on a rollercoaster this year, with a recent dip of 4.09% in a day following a prolonged rally that has lifted its year-to-date share price return to an impressive 212%. Despite pockets of volatility, long-term momentum is clearly...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7132000-choice1-main-header/1585186724276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7132000-choice1-main-header/1585186724276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-hood/robinhood-markets/news/a-look-at-robinhood-hood-valuation-following-recent-volatili","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-hood/robinhood-markets/news/a-look-at-robinhood-hood-valuation-following-recent-volatili","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4127","HOOD","LU1861558580.USD","BK4547","BK4539","LU1861559042.SGD"],"gpt_icon":1},{"id":"2588206851","title":"Ryan Specialty Rebrands NAPL Team as Ryan Financial Lines in Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2588206851","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588206851?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:04","pubTimestamp":1764698665,"startTime":"0","endTime":"0","summary":"Ryan Specialty Holdings Inc. has announced the rebranding of its North American Professional Liability  team as Ryan Financial Lines, marking a significant step in its international expansion strategy. The move integrates the NAPL team's deep expertise in professional liability into the broader Ryan Financial Lines platform, strengthening its international portfolio. Operating from Ryan Specialty's London office, industry veterans Patrick Comerford and Clive Moore have been appointed Managing Directors of the international arm, enhancing the company's global reach and capabilities in delivering financial lines products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ryan Specialty Holdings Inc. published the original content used to ge","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL80nJ2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RYAN","BK4173","BK4539"],"gpt_icon":0},{"id":"2588068594","title":"RxSight Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068594","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588068594?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:03","pubTimestamp":1764698580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXST/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 13:03 ET (18:03 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4198","RXST"],"gpt_icon":0},{"id":"2588068167","title":"Robinhood CEO Says Gen Z Is Obsessed With 'Grandparent' Products Like Cassette Tapes And Walkmans—And Now They're Opening Retirement Accounts At 19","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068167","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588068167?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:01","pubTimestamp":1764698460,"startTime":"0","endTime":"0","summary":"There was a time when retirement accounts were something you opened in your 30s, maybe after buying a house or having kids. But according to Robinhood co-founder and CEO Vlad Tenev, that timeline may already be outdated. The generation known more for side hustles, digital wallets, and instant everything is now opening Roth IRAs at 19—and not because anyone told them to.Tenev recently appeared on the \"Uncapped with Jack Altman\" podcast, where he described what he called \"a broader trend of things that are old and kind of…maybe that your grandparents would use, being cool again.\". He was talking about vinyl and cassette tapes, but the retro revival has crept into the financial world too. \"Now Gen Z's are opening retirement accounts at 19 years old,\" he said. And not just as a quirky experiment.Even so, the idea that a generation often seen as short-sighted is thinking long-term flips a familiar narrative on its head. And for older readers watching their own children or grandchildren take","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/02/Teens-100-000-College-Dream-Meets-Harsh-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/02/Teens-100-000-College-Dream-Meets-Harsh-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/personal-finance/management/25/12/49167575/robinhood-ceo-says-gen-z-is-obsessed-with-grandparent-products-like-cassette-tapes-and-walkmans-and-now-theyre-opening-retirement-accounts-at-19","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/personal-finance/management/25/12/49167575/robinhood-ceo-says-gen-z-is-obsessed-with-grandparent-products-like-cassette-tapes-and-walkmans-and-now-theyre-opening-retirement-accounts-at-19","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4127","HOOD","BK4539","BK4547"],"gpt_icon":1},{"id":"2588068587","title":"Coinbase Global: Aware That Some Users May Be Experiencing Delayed Sends and Receives on Osmosis Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588068587?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:00","pubTimestamp":1764698459,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X813B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4551","COIN","BK4585","LU1861217088.USD","BK4600","LU1861220207.SGD","BK4588","LU1861558580.USD","LU1861559042.SGD","LU2360107671.USD","BK4554","BK4516","CONL","BK4112","BK4596","BK4595","BK4539"],"gpt_icon":0},{"id":"2588068582","title":"Coinbase Global Inc: Buys, Sells, and Fiat Withdrawals/Deposits Remain Unaffected on Osmosis Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588068582?lang=en_us&edition=fundamental","pubTime":"2025-12-03 02:00","pubTimestamp":1764698459,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X813B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4554","CONL","LU1861217088.USD","LU1861220207.SGD","BK4539","BK4595","LU1861558580.USD","LU1861559042.SGD","BK4112","BK4596","LU2360107671.USD","BK4585","BK4516","BK4600","BK4535","BK4551","COIN"],"gpt_icon":0},{"id":"2588050489","title":"Gold Down Over 1%; Signet Shares Fall After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050489","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588050489?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:29","pubTimestamp":1764696559,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49166700/gold-down-over-1-signet-shares-fall-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4200","BK4539","LU1548497426.USD","LU1861220033.SGD","LU2272731782.SGD","LU1861215975.USD","LU0154245756.USD","LU0719512351.SGD","LU1992135472.HKD","BK4077","BK4137","LU1720051017.SGD","LU1923623000.USD","EB","ABTC","LU1951200564.SGD","BK4139","VSTS","BK4608","LU2272731600.USD","BK4023","BK4585","BK4607","SIG","LU2087625088.SGD",".IXIC","BK4588","LU2357305700.SGD","LU2286300806.USD","LU0823434740.USD","LU1992135399.USD","LU0390134368.USD","PLRZ","LU0154245673.USD","BK4116","LU1720051108.HKD","LU0082616367.USD","BK4108","LU0353189680.USD","JANX","BK4613","LU1951198990.SGD","LU0353189763.USD","LU0823434583.USD"],"gpt_icon":1},{"id":"2588050760","title":"What's Going On With Cancer Firm Kazia Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050760","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588050760?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:21","pubTimestamp":1764696060,"startTime":"0","endTime":"0","summary":"Kazia announced a private placement of $50 million in equity securities. Proceeds will fund clinical development and extend cash runway.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/02/Product-Affected.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/02/Product-Affected.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49166519/whats-going-on-with-cancer-firm-kazia-therapeutics","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49166519/whats-going-on-with-cancer-firm-kazia-therapeutics","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4007","LENZ","KZIA","BK4539","BK4139"],"gpt_icon":0},{"id":"2588505062","title":"Oklo Volatility Play: Traders Get A New 2X Inverse Weapon With Defiance's OKLS","url":"https://stock-news.laohu8.com/highlight/detail?id=2588505062","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588505062?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:12","pubTimestamp":1764695520,"startTime":"0","endTime":"0","summary":"The OKLS ETF gives traders a high-powered way to make short-term bearish bets on Oklo stock with daily -2x exposure.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/02/Oklo-Inc-.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/02/Oklo-Inc-.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/new-etfs/25/12/49166298/oklo-volatility-play-traders-get-a-new-2x-inverse-weapon-with-defiances-okls","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/new-etfs/25/12/49166298/oklo-volatility-play-traders-get-a-new-2x-inverse-weapon-with-defiances-okls","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4539","OKLO","BK4081","OKLS","BK4606"],"gpt_icon":1},{"id":"2588057076","title":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST","url":"https://stock-news.laohu8.com/highlight/detail?id=2588057076","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588057076?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:00","pubTimestamp":1764694807,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. ESTS&P 500 .SPXTop PerformersPercent ChangeBoeing Co BA.N+8.4%Intel Corp INTC.OQ+7.1%Applovin Corp APP.OQ+5.7%NXP Semiconductors NV NXPI.OQ+5.0%Estee Lauder Companies Inc EL.N+4.9%Bottom PerformersPercent ChangeSandisk Corp SNDK.OQ-4.5%Best Buy Co Inc BBY.N-3.6%International Paper Co IP.N-3.4%Packaging Corp of America PKG.N-3.3%Newmont Corporation NEM.N-3.2%As of 12:00 p.m., the S&P 500 .SPX gained 6.63 points, or 0.10%, to 6,819.26 and had posted 9 new 52-week highs and 2 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nL8N3X81KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348723411.USD","LU1883866441.USD","PKG","LU0075056555.USD","BBY","LU0788108826.HKD","LU2552382132.HKD","IP","LU2326559502.SGD","LU0345780950.USD","BK4516","LU0612318385.USD","INTC","LU2498475776.HKD","APP","LU0496367417.USD","BK4539","BK4551","LU1852331112.SGD","LU0353189680.USD","LU2272731782.SGD","BK4575","BK4023","LU2360106780.USD","BK4604","LU2404859667.USD","NEM","BK4612","LU0345780521.USD","IE00BD6J9T35.USD","BK4076","BK4554","LU2552382215.SGD","BK4570","LU0300736062.USD","LU0498741114.HKD","BK4585","BA","LU2360107325.USD","SNDK","LU0868494708.USD","LU2247934214.USD","EL","LU1046421795.USD","LU1718418525.SGD","NXPI","IE00B19Z9Z06.USD","BK4527","BK4136","LU1223082519.USD"],"gpt_icon":1},{"id":"2588057788","title":"How to build the perfect investor: 50% Generation X and 50% Gen Z","url":"https://stock-news.laohu8.com/highlight/detail?id=2588057788","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588057788?lang=en_us&edition=fundamental","pubTime":"2025-12-03 00:57","pubTimestamp":1764694620,"startTime":"0","endTime":"0","summary":"What today's younger investors can learn from their parents, and vice versa. Gen Z members may not be buying houses - but they're investing like no generation before them.Generation Z get mocked at times for taking the dodgy investing advice they heard in a 30-second TikTok video, but a closer look shows they are more financially savvy than they get credit for.A growing body of research finds that America's youngest investors are learning about money online, trading equities on their phones and exploring alternate assets in a way previous generations never did. And they're beginning their investing journeys much earlier: Charles Schwab reports that the average Gen Z member started investing at 19 - compared with age 25 for millennials, and as late as 32 on average for Generation X members.But some financial experts suggest that this financial strain could also be encouraging Gen Z to invest earlier in the first place. \"There's some undertones of Gen Z thinking they are not able to affo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4588","VOO","LU1861559042.SGD","BK4127","BK4585","LU1861558580.USD","BK4547","BK4581","BK4559","HOOD","BK4539"],"gpt_icon":1},{"id":"2588524810","title":"SentinelOne Unveils New Innovations and Integrations With AWS to Accelerate Customers’ AI Initiatives at AWS Re:Invent 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588524810","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588524810?lang=en_us&edition=fundamental","pubTime":"2025-12-03 00:01","pubTimestamp":1764691260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA81WSTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4561","BK4539","LU2286300806.USD","BK4560","BK4097","BK4588","S","BK4585"],"gpt_icon":0},{"id":"2588340059","title":"BRIEF-Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology For Oligomer-Selective Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2588340059","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588340059?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:13","pubTimestamp":1764684837,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology For Oligomer-Selective Antibodies Dec 2 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O:ACUMEN PHARMACEUTICALS HIGHLIGHTS ENHAN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA3PZWFX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2588056603","title":"Press Release: Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG","url":"https://stock-news.laohu8.com/highlight/detail?id=2588056603","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588056603?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:50","pubTimestamp":1764683400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec. 02, 2025  -- Ernexa Therapeutics , an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the appointment of Dr. Ira S. Winer, M.D., Ph.D., FACOG, to its Scientific and Medical Advisory Board.Dr. Winer is a nationally recognized gynecologic oncologist and translational scientist. His expertise in women's oncology, immunotherapy, and early-phase clinical development further strengthens Ernexa's capabilities as it advances its proprietary induced mesenchymal stem cells  platform and lead program, ERNA-101, toward key milestones, including first-in-human trials.\"We are delighted to welcome Dr. Winer to our Advisory Board,\" said Sanjeev Luther, President and CEO of Ernexa Therapeutics. \"His deep clinical and translational experience in women's oncology directly supports our mission to advance treatments for advanced cancer and autoimmune disease. As we move ERNA-101 forward in ovarian cancer ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","BK4539","LENZ","ERNA"],"gpt_icon":0}],"pageSize":20,"totalPage":50,"pageCount":1,"totalSize":993,"code":"91000000","status":"200"}]}}